Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03766412 · ClinicalTrials.gov registry record
High School Start Time and Teen Migraine Frequency
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 256
- Enrollment target
NCT03766412: Completed study, sponsored by University of California, San Francisco.
NCT03766412 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 256 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03766412 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 256 participants
- Enrollment target
Study Summary
Migraine is common in adolescents and can cause missed school and disability. The American Academy of Pediatrics (AAP) recommends that high schools start no earlier than 8:30 AM in order to accommodate the physiologic needs of adolescents-whose brains naturally want to fall asleep later and wake up later and who still need to get at least 8 hours of sleep per night to function optimally-however, only about 18% of US high schools comply with this AAP recommendation. There is a relationship between adequate sleep and migraine. The investigators aim to determine whether high school students with migraine who attend high schools that comply with this AAP recommendation have lower migraine frequency than those that do not. If so, it would argue for advocating for changes in high school policy to optimize health of adolescents with migraine.
Primary Outcome
How many headache days experienced in the last month
Interventions
- OTHER High School start time
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2018-10-15 |
What the finished NCT03766412 record still lists
NCT03766412 is an observational study that tracks outcomes without assigning an intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which High School start time is the first listed.
NCT03766412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03766412 about?
NCT03766412 is a clinical study titled "High School Start Time and Teen Migraine Frequency". Migraine is common in adolescents and can cause missed school and disability. The American Academy of Pediatrics (AAP) recommends that high schools start no earlier than 8:30 AM in order to accommodate the physiologic needs of adolescents-whose brains naturally want to fall asleep later and wake up...
What is the current status of trial NCT03766412?
This trial is currently completed. The enrollment target is 256 participants. The study started on 2018-10-01. Estimated completion is 2018-10-15.
What interventions are being tested in trial NCT03766412?
The interventions under investigation include: High School start time (OTHER).
Who is sponsoring clinical trial NCT03766412?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02464696 · 256 participants · NA
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- NCT03793062 · 256 participants
Genetic and Epigenetic Basis of Chronic Wounds
- NCT04322318 · 256 participants · Phase 2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- NCT04468360 · 256 participants · Phase 2
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI